Latest Insider Transactions at Cumberland Pharmaceuticals Inc (CPIX)
This section provides a real-time view of insider transactions for Cumberland Pharmaceuticals Inc (CPIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CUMBERLAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CUMBERLAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
75
+0.04%
|
$300
$4.47 P/Share
|
|
Dec 03
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
18
+0.0%
|
$72
$4.47 P/Share
|
|
Dec 03
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
18
+0.12%
|
$72
$4.47 P/Share
|
|
Dec 03
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
21
+0.11%
|
$84
$4.47 P/Share
|
|
Dec 02
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
90
+0.05%
|
$270
$3.84 P/Share
|
|
Dec 02
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
75
+0.04%
|
$225
$3.84 P/Share
|
|
Dec 02
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
18
+0.0%
|
$54
$3.84 P/Share
|
|
Dec 02
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
18
+0.12%
|
$54
$3.84 P/Share
|
|
Dec 02
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
21
+0.11%
|
$63
$3.84 P/Share
|
|
Dec 01
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
90
+0.05%
|
$360
$4.14 P/Share
|
|
Dec 01
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
75
+0.04%
|
$300
$4.14 P/Share
|
|
Dec 01
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
18
+0.0%
|
$72
$4.14 P/Share
|
|
Dec 01
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
18
+0.12%
|
$72
$4.14 P/Share
|
|
Dec 01
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
21
+0.11%
|
$84
$4.14 P/Share
|
|
Nov 30
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
175
+0.1%
|
$700
$4.61 P/Share
|
|
Nov 30
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
150
+0.08%
|
$600
$4.61 P/Share
|
|
Nov 30
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
35
+0.0%
|
$140
$4.61 P/Share
|
|
Nov 30
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
35
+0.24%
|
$140
$4.61 P/Share
|
|
Nov 30
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.22%
|
$168
$4.61 P/Share
|
|
Nov 29
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
175
+0.1%
|
$350
$2.23 P/Share
|
|
Nov 29
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
150
+0.08%
|
$300
$2.23 P/Share
|
|
Nov 29
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
35
+0.0%
|
$70
$2.23 P/Share
|
|
Nov 29
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
35
+0.24%
|
$70
$2.23 P/Share
|
|
Nov 29
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.22%
|
$84
$2.23 P/Share
|
|
Nov 26
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
175
+0.1%
|
$350
$2.26 P/Share
|
|
Nov 26
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
150
+0.08%
|
$300
$2.26 P/Share
|
|
Nov 26
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
35
+0.0%
|
$70
$2.26 P/Share
|
|
Nov 26
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
35
+0.24%
|
$70
$2.26 P/Share
|
|
Nov 26
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.22%
|
$84
$2.26 P/Share
|
|
Nov 24
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
175
+0.1%
|
$350
$2.31 P/Share
|
|
Nov 24
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
150
+0.08%
|
$300
$2.31 P/Share
|
|
Nov 24
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
35
+0.0%
|
$70
$2.31 P/Share
|
|
Nov 24
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
35
+0.24%
|
$70
$2.31 P/Share
|
|
Nov 24
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.22%
|
$84
$2.31 P/Share
|
|
Nov 23
2021
|
John M. Hamm VP Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,800
+35.85%
|
$7,600
$2.35 P/Share
|
|
Nov 23
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.29 P/Share
|
|
Nov 23
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.29 P/Share
|
|
Nov 23
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.29 P/Share
|
|
Nov 23
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.29 P/Share
|
|
Nov 23
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.22%
|
$84
$2.29 P/Share
|
|
Nov 22
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.35 P/Share
|
|
Nov 22
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.35 P/Share
|
|
Nov 22
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.35 P/Share
|
|
Nov 22
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.35 P/Share
|
|
Nov 22
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.22%
|
$84
$2.35 P/Share
|
|
Nov 19
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.55 P/Share
|
|
Nov 19
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.55 P/Share
|
|
Nov 19
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.55 P/Share
|
|
Nov 19
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.55 P/Share
|
|
Nov 19
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.22%
|
$84
$2.55 P/Share
|